Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Applied Therapeutics, Inc. - Common Stock
(NQ:
APLT
)
1.280
+0.030 (+2.40%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Applied Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Applied Therapeutics Provides Update Following Meeting with FDA
September 29, 2025
From
Applied Therapeutics
Via
GlobeNewswire
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); Elevance Health Inc. (NYSE: ELV); and V.F. Corp. (NYSE: VFC): Grabar Law Office is Investigating Claims on Your Behalf
September 17, 2025
From
Grabar Law Office
Via
GlobeNewswire
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); Ibotta Inc. (NYSE: IBTA); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law Office is Investigating Claims on Your
September 15, 2025
From
Grabar Law Office
Via
GlobeNewswire
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); LuxUrban Hotels Inc. (OTC: LUXH); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims
September 12, 2025
From
Grabar Law Office
Via
GlobeNewswire
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Lantheus Holdings, Inc. (NASDAQ: LNTH); Savara Inc. (NASDAQ: SVRA); and Unicycive Therapeutics, Inc. (NASDAQ: UNCY): Grabar Law Office is Investigating Claims on Your
September 11, 2025
From
Grabar Law Office
Via
GlobeNewswire
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); Elevance Health Inc. (NYSE: ELV); LifeMD, Inc. (NASDAQ: LFMD); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf
September 10, 2025
From
Grabar Law Office
Via
GlobeNewswire
Applied Therapeutics Reports Second Quarter 2025 Financial Results
August 13, 2025
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics Announces Key Leadership Appointments
June 17, 2025
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
May 18, 2025
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics Reports First Quarter 2025 Financial Results
May 13, 2025
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
May 09, 2025
Late-breaking oral presentation to include full 12-month clinical data from INSPIRE registrational Phase 3 trial in addition to topline 18-month and 24-month data from patients prior to open-label...
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results
April 14, 2025
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission
March 31, 2025
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer
March 19, 2025
Dr. Baumgartner will advance Applied’s preparation for upcoming regulatory interactions
From
Applied Therapeutics
Via
GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Applied Therapeutics
February 18, 2025
From
Faruqi & Faruqi, LLP
Via
Business Wire
Final APLT Deadline Reminder: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
February 18, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Final APLT Deadline Reminder: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
February 18, 2025
RADNOR, PA - February 18, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Applied...
Via
TheNewswire.com
Topics
Lawsuit
APLT Deadline in 1 Day: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
February 17, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
APLT Deadline in 1 Day: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
February 17, 2025
RADNOR, PA - February 17, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Applied...
Via
TheNewswire.com
Topics
Lawsuit
APLT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT
February 17, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
DEADLINE TOMORROW: Kaplan Fox Reminds Investors of a Deadline for a Securities Class Action Lawsuit Against Applied Therapeutics (APLT)
February 17, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
DEADLINE TOMORROW: Kaplan Fox Reminds Investors of a Deadline for a Securities Class Action Lawsuit Against Applied Therapeutics (APLT)
February 17, 2025
NEW YORK - February 17, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or the...
Via
TheNewswire.com
Topics
Lawsuit
APLT Deadline: Rosen Law Firm Urges Applied Therapeutics, Inc. (NASDAQ: APLT) Investors to Contact the Firm for Information About Their Rights
February 15, 2025
From
The Rosen Law Firm, P.A.
Via
Business Wire
APLT Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
February 15, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
APLT Deadline in 3 Days: Kessler Topaz Meltzer & Check, LLP Reminds Applied Therapeutics, Inc. (APLT) Investors of Filing Deadline in Class Action Lawsuit
February 15, 2025
RADNOR, PA - February 15, 2025 (NEWMEDIAWIRE) - The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Applied...
Via
TheNewswire.com
Topics
Lawsuit
Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
February 15, 2025
NEW YORK - February 15, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or the...
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Kaplan Fox Reminds Investors of a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
February 15, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Deadline Soon: Applied Therapeutics, Inc. (APLT) Investors Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
February 14, 2025
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
February 14, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Kaplan Fox Alerts Investors to a Deadline for a Securities Fraud Class Action Lawsuit Against Applied Therapeutics (APLT)
February 14, 2025
NEW YORK - February 14, 2025 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or the...
Via
TheNewswire.com
Topics
Fraud
Lawsuit
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today